SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-23-045058
Filing Date
2023-06-01
Accepted
2023-06-01 16:31:06
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea178928-f1_altamiratherap.htm F-1 288605
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, BERMUDA COUNSEL TO THE COMPANY, AS TO ea178928ex5-1_altamirathe.htm EX-5.1 20760
3 CONSENT OF DELOITTE AG ea178928ex23-1_altamirathe.htm EX-23.1 2508
4 FILING FEE TABLE ea178928ex-fee_altamirathe.htm EX-FILING FEES 27218
5 GRAPHIC image_001.jpg GRAPHIC 3539
6 GRAPHIC ex5-1_001.jpg GRAPHIC 4273
  Complete submission text file 0001213900-23-045058.txt   351440
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-272336 | Film No.: 23985178
SIC: 2834 Pharmaceutical Preparations